{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019dd923-622c-750b-8b9b-a88f4b1599da",
  "slug": "2a2da42210b1",
  "title": "Valeant Pharmaceuticals International (VRX)",
  "subtitle": "Pershing Square Holdings · 2016-03",
  "author": "Pershing Square Holdings",
  "date": "2016-03-21 00:00:00",
  "pageCount": 1,
  "kind": "press-release",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "targetCompany": "Valeant Pharmaceuticals International",
  "targetTicker": "VRX",
  "document": {
    "id": "019dd923-622c-750b-8b9b-a88f4b1599da",
    "slug": "2a2da42210b1",
    "title": "Valeant Pharmaceuticals International (VRX)",
    "rawTitle": "PSH Communication Regarding Developments at Valeant2",
    "authorId": "01_Pershing_Square",
    "authorName": "Pershing Square Holdings",
    "authorDisplay": "Pershing Square Holdings",
    "kind": {
      "slug": "press-release",
      "label": "Press release"
    },
    "sourceType": {
      "slug": "activist_investor",
      "label": "Activist investor"
    },
    "fileName": "2016-03-PSH-Communication-Regarding-Developments-at-Valeant2.pdf",
    "sourceUrl": "http://ir.valeant.com/news-releases/2016/03-21-2016-125936508",
    "sourceDate": "2016-03-21 00:00:00",
    "presentationDate": "2016-03-21 00:00:00",
    "ingestedAt": "2026-04-23 00:21:35+00",
    "status": "ready",
    "pageCount": 1,
    "orientation": "portrait",
    "aspectRatio": 0.77272725,
    "targetCompany": "Valeant Pharmaceuticals International",
    "targetTicker": "VRX",
    "metadata": {
      "local_root": "/tmp/legacy-images/2a2da42210b1",
      "activist_firm": "Pershing Square",
      "origin_corpus": "contrarian",
      "extraction_seconds": 26.859918117523193
    }
  },
  "coverage": {
    "pageCount": 1,
    "pagesIndexed": 1,
    "pagesWithImages": 1,
    "pagesWithMetadata": 1,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 7,
    "chartCount": 0,
    "metricSlides": 0,
    "toolMatches": 0,
    "documentToolMatches": 0,
    "frameworkMatches": 0,
    "arcMatches": 1,
    "beatMatches": 1,
    "loopMatches": 0,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "AIDA",
          "slug": "aida",
          "status": "active",
          "bestFor": "Marketing presentations, product launches, sales enablement",
          "canonId": "019dd956-5fb4-77aa-866d-f9bdd47803af",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Attention -> Interest -> Desire -> Action",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "003a6368-34c2-4aeb-8eb1-34ab0f42a7db",
        "evidence": "The document is a press release, which typically follows the AIDA (Attention, Interest, Desire, Action) structure to communicate effectively with shareholders.",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:02:47.989691+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 1,
        "arc": {
          "name": "AIDA",
          "slug": "aida",
          "status": "active",
          "bestFor": "Marketing presentations, product launches, sales enablement",
          "canonId": "019dd956-5fb4-77aa-866d-f9bdd47803af",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Attention -> Interest -> Desire -> Action",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 1,
        "name": "Attention",
        "beatId": "376645f4-9b64-4592-a1d1-5b0a48ed4eea",
        "matchId": "003a6368-34c2-4aeb-8eb1-34ab0f42a7db",
        "beatType": {
          "name": "Attention",
          "slug": "aida-attention",
          "status": "active",
          "canonId": "019dd9b8-1086-7099-85c1-2f9cae7ea19d",
          "version": 1,
          "description": null
        },
        "evidence": "The press release aims to grab the attention of shareholders regarding developments at Valeant Pharmaceuticals International, Inc.",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Hook",
          "slug": "hook",
          "status": "active",
          "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
          "version": 1,
          "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [],
    "tools": [],
    "frameworks": [],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "function": "summarize",
      "imagePath": "https://imgproxy.kitesheet.com/XkETKPN-TvUU2wF3XyhBd_8iyfC0J8TWixN9HYX367U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5qcGc",
      "rawType": "press-release",
      "block": null,
      "metadata": {
        "slideType": "press-release",
        "slideTypeCanon": null,
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 63,
        "componentCount": 7,
        "textChars": 806,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": [
          "paragraph"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:02:11.639+00",
          "seconds": 2.974,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9b-a88f4b1599da/1",
        "deck": "/decks/019dd923-622c-750b-8b9b-a88f4b1599da",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9b-a88f4b1599da#slide-1",
        "deckJson": "/decks/019dd923-622c-750b-8b9b-a88f4b1599da.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.04,
            "w": 0.78,
            "x": 0.11,
            "y": 0.16
          },
          "kind": "paragraph",
          "text": "Amsterdam, 21 Mar. 2016 //- Pershing Square Holdings, Ltd. today released an email to investors. The text of the email is set forth below:",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "442f04a0-f64b-414a-95c7-81413b31ca05",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.78,
            "x": 0.11,
            "y": 0.21
          },
          "kind": "paragraph",
          "text": "Dear Pershing Square Investor, Today Valeant Pharmaceuticals International, Inc. issued a press release announcing developments at the company. Please find below a link to the press release on the Valeant web site.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b7543e2-b8f8-4795-8fe5-ed3c71a92d7f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.78,
            "x": 0.11,
            "y": 0.45
          },
          "kind": "paragraph",
          "text": "Pershing Square Holdings, Ltd. (PSH:NA) is an investment holding company structured as a closed end fund that makes concentrated investments principally in North American companies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "810d704a-f8ef-40a8-889e-3ae80167839f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.11,
            "y": 0.28
          },
          "kind": "paragraph",
          "text": "http://ir.valeant.com/news-releases/2016/03-21-2016-125936508",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eafeee1e-86c4-4f9b-a833-2d0f331a3624",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.2,
            "x": 0.11,
            "y": 0.31
          },
          "kind": "paragraph",
          "text": "Kind regards, Pershing Square IR ir@persq.com",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ebdc8c24-cf4c-4cf8-bd3e-bfa1f238db05",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.2,
            "y": 0.09
          },
          "kind": "title",
          "text": "Pershing Square Holdings, Ltd. Communicates with Shareholders Regarding Developments at Valeant Pharmaceuticals International, Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9ed6b8f-8808-42bc-b570-c4bec216c628",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.11,
            "y": 0.43
          },
          "kind": "title",
          "text": "About Pershing Square Holdings, Ltd.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:02:11.639+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "916f11fd-2190-4d60-b719-bd4f311d3de1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 1,
          "arc": {
            "name": "AIDA",
            "slug": "aida",
            "status": "active",
            "bestFor": "Marketing presentations, product launches, sales enablement",
            "canonId": "019dd956-5fb4-77aa-866d-f9bdd47803af",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Attention -> Interest -> Desire -> Action",
            "description": null,
            "familyLabel": null
          },
          "from": 1,
          "name": "Attention",
          "beatId": "376645f4-9b64-4592-a1d1-5b0a48ed4eea",
          "matchId": "003a6368-34c2-4aeb-8eb1-34ab0f42a7db",
          "beatType": {
            "name": "Attention",
            "slug": "aida-attention",
            "status": "active",
            "canonId": "019dd9b8-1086-7099-85c1-2f9cae7ea19d",
            "version": 1,
            "description": null
          },
          "evidence": "The press release aims to grab the attention of shareholders regarding developments at Valeant Pharmaceuticals International, Inc.",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/S2qiVGxxkPthQD6Du653fgO4M4NbiI4qTDV8CObmMqE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5qcGc",
      "imagePathAlt": "https://imgproxy.kitesheet.com/hY2ot2XmnVingQA293aFySRoBXiY-1UAghBvU2ImeoM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5wbmc",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/yr1IzIAQBtVdpHLHLcjVqqItIHDpKHiULIhJ6PBEF1E/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5wbmc"
    }
  ],
  "arcBeats": [
    {
      "from": 1,
      "to": 1,
      "label": "Attention",
      "description": "The press release aims to grab the attention of shareholders regarding developments at Valeant Pharmaceuticals International, Inc."
    }
  ],
  "loops": []
}